Nociceptive mechanisms involved in the acute and chronic phases of a complex regional pain syndrome type 1 model in mice

• Published in: European journal of pharmacology Vol. 859; p. 172555
• Main Authors: De Prá, Samira Dal Toé, Antoniazzi, Caren Tatiane de David, Ferro, Paula Ronsani, Kudsi, Sabrina Qader, Camponogara, Camila, Fialho, Maria Fernanda Pessano, Rigo, Flávia Karine, Gomez, Marcus Vinícius, Bochi, Guilherme Vargas, Moresco, Rafael Noal, Oliveira, Sara Marchesan, Trevisan, Gabriela
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.09.2019
• Subjects: Acute Disease; Allodynia; Animals; Calcium channels; Chronic Disease; Disease Models, Animal; Female; Hyperalgesia - complications; Male; Mice; Mice, Inbred C57BL; Neuropathic pain; Nociception; Pregabalin; Reflex Sympathetic Dystrophy - complications; Reflex Sympathetic Dystrophy - metabolism; Reflex Sympathetic Dystrophy - physiopathology; Spider peptide; TRPA1; Allodynia; Calcium channels; Pregabalin; TRPA1; Spider peptide; Neuropathic pain
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/j.ejphar.2019.172555

Complex regional pain syndrome I (CRPS-I) is a chronic painful pathology still undertreated. CTK 01512–2 is a recombinant version of the spider peptide Phα1β, and it functions as a voltage-gated calcium channel blocker and a transient receptor potential ankyrin 1 (TRPA1) antagonist with antinociceptive effect in different pain models. Here, we investigate the mechanisms involved in the acute and chronic nociceptive phases of a model of CPRS-I in mice and assess the antinociceptive effect of CTK 01512–2 using this model. Adult male and female mice C57BL/6 (20–30 g) were used to determine mechanical (von Frey test) or cold (acetone test) allodynia induction. Inflammatory parameters (serum and tibial nerve lactate levels, hind paw temperature and edema, or tissue cell infiltration) were evaluated after chronic post-ischemia pain (CPIP, a model of CPRS-I) induction. Anti-inflammatory and anti-neuropathic drugs or CTK 01512–2 were tested. First, we detected that CPIP-induced mechanical and cold allodynia in male and female mice in a similar way. In the acute phase (1 day after CPIP), an increase in inflammatory parameters were observed, as well as the anti-allodynic effect of anti-inflammatory compounds. In the chronic phase (17 days after CPIP), mice exhibited mechanical and cold allodynia, and anti-neuropathic drugs induced antinociception, while no inflammatory alterations were found. CTK 01512–2 reversed the CPIP allodynic effect in both nociceptive phases. Thus, this CPRS-I model can be used to understand the mechanisms involved in CPRS-I induced pain and inflammation. Besides, we observed that CTK 01512-2 has a valuable antinociceptive effect in this pain model. [Display omitted]